Cryo Cell International Inc (CCEL) financial statements (2021 and earlier)

Company profile

Business Address 700 BROOKER CREEK BLVD
OLDSMAR, FL 34677
State of Incorp. DE
Fiscal Year End November 30
SIC 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

11/30/2020
Q4
8/31/2020
Q3
5/31/2020
Q2
2/29/2020
Q1
11/30/2019
Q4
8/31/2019
Q3
5/31/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10899787
Cash and cash equivalents10888776
Short-term investments0011111
Receivables6766666
Inventory, net of allowances, customer advances and progress billings1111111
Inventory1111111
Prepaid expense1110111
Other current assets0000000
Total current assets:19171717151615
Noncurrent Assets
Property, plant and equipment2222222
Other noncurrent assets26262626262424
Total noncurrent assets:28282828272626
TOTAL ASSETS:46444545434241
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4234322
Accounts payable1111111
Accrued liabilities3123211
Deferred revenue999999 
Debt3333333
Contract with customer, liability9
Other undisclosed current liabilities00     
Total current liabilities:16141516151414
Noncurrent Liabilities
Liabilities, other than long-term debt32343535343535
Other liabilities32343535343535
Total noncurrent liabilities:32343535343535
Total liabilities:49485051504949
Stockholders' equity
Stockholders' equity attributable to parent(3)(4)(5)(6)(7)(7)(8)
Common stock0000000
Treasury stock, value(21)(21)(21)(21)(21)(20)(20)
Additional paid in capital37363636363636
Accumulated deficit(19)(20)(21)(22)(22)(23)(24)
Total stockholders' equity:(3)(4)(5)(6)(7)(7)(8)
TOTAL LIABILITIES AND EQUITY:46444545434241

Income statement (P&L) ($ in millions)

11/30/2020
Q4
8/31/2020
Q3
5/31/2020
Q2
2/29/2020
Q1
11/30/2019
Q4
8/31/2019
Q3
5/31/2019
Q2
Revenues8888888
Cost of revenue(2)(2)(3)(3)(2)(3)(4)
Cost of goods and services sold(2)(2)(2)(3)(2)(3)(3)
Gross profit:5655664
Operating expenses(4)(3)(4)(4)(4)(4)(4)
Other undisclosed operating income00 0   
Operating income:2221220
Nonoperating expense(0)(2)(0)(0)(0)(0)(0)
Loss on contract termination (1)     
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes0000000
Income from continuing operations before income taxes:2111120
Income tax expense(1)(0)(0)(0)(0)(0)(0)
Net income available to common stockholders, diluted:1111110

Comprehensive Income ($ in millions)

11/30/2020
Q4
8/31/2020
Q3
5/31/2020
Q2
2/29/2020
Q1
11/30/2019
Q4
8/31/2019
Q3
5/31/2019
Q2
Net income:1111110
Comprehensive income, net of tax, attributable to parent:1111110

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: